Alkem Laboratories informs about updates

21 Mar 2026 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (SEBI LODR Regulations) and in furtherance to earlier intimation dated 10th December 2025, captioned ‘GMP Inspection by Malta Medicines Authority at Alkem’s manufacturing facility located at Daman, India’, Alkem Laboratories has informed that the Company has received a ‘Certificate of GMP Compliance of a Manufacturer’ from the Malta Medicines Authority with respect to the Company’s manufacturing facility located at Daman, India. The said certificate is valid for a period of 3 years from the date of inspection being 09th December, 2025. A copy of this disclosure will be made available on the Company’s website in accordance with Regulation 30(8) of the SEBI LODR Regulations.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5303.30 -40.20 (-0.75%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×